Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled time : 14:15 save search
Rafael Pharmaceuticals Announces First Patient Enrolled in APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma
Published: 2021-11-11 (Crawled : 14:15) - globenewswire.com
RFL 4 | $1.78 -1.11% -5.06% 8.2K
|
Finance
|
| O: 0.29%
H: 5.17%
C: 0.58%
phase 1 cpi-613 trial enroll
Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS
Published: 2021-11-11 (Crawled : 14:15) - globenewswire.com
ADAP | $0.987 -4.18% -3.23% 1.2M
|
Health Technology
|
| O: -3.29%
H: 3.0%
C: -6.0%
positive results positive results trial
MKS Instruments to Participate in Deutsche Bank’s Industrial Conference
Published: 2021-11-08 (Crawled : 14:15) - globenewswire.com
MKSI | $114.8 -4.71% -4.95% 530K
|
Electronic Technology
|
| O: 0.22%
H: 0.54%
C: -1.11%
trial conference
American Airlines to Present at 2021 Baird Global Industrial Conference
Published: 2021-11-03 (Crawled : 14:15) - globenewswire.com
GIC | News | $39.99 -2.25% 0.0% 52K
|
Retail Trade
|
| O: -2.26%
H: 0.0%
C: 0.0%
AAL | $13.89 6.6% 6.19% 49M
|
Transportation
|
| O: -0.05%
H: 4.29%
C: 4.09%
trial conference
BioVie Announces FDA Authorization to Initiate Phase 2 Trials Assessing NE3107’s Pro-motoric Activity in Parkinson’s Disease
Published: 2021-10-26 (Crawled : 14:15) - biospace.com/
BIVI | $0.4714 -3.4% -1.27% 610K
|
Health Technology
|
| O: 6.04%
H: 0.0%
C: 0.0%
disease fda phase 2 parkinson trials trial
With Market Size Valued at $1.3 Billion by 2026, it`s a Healthy Outlook for the Global Industrial Communication Gateways Market
Published: 2021-10-19 (Crawled : 14:15) - prnewswire.com
GIC | News | $39.99 -2.25% 0.0% 52K
|
Retail Trade
|
| O: 0.65%
H: 2.29%
C: 1.97%
EMR | $109.81 -1.51% 0.56% 1.9M
|
Producer Manufacturing
|
| O: 0.7%
H: 0.15%
C: -0.02%
CSCO | News | $47.79 -0.27% -0.29% 10M
|
Technology Services
|
| O: 0.18%
H: 0.89%
C: 0.81%
communication trial
USD 642.89 mn growth in Industrial Food Dryer Market | Increase in demand for Freeze Drying Equipment to Accelerate Market Demand | 17,000+ Technavio Research Reports
Published: 2021-10-15 (Crawled : 14:15) - prnewswire.com
ADRZY | $12.1275 -17.72% 2.8K
|
Manufacturing
| Email alert
Add to watchlist
ADRZF | $58.8 -0.83% 1.5K
|
Producer Manufacturing
| Email alert
Add to watchlist
food ema growth research trial
Sorrento Receives FDA Clearance to Proceed With Clinical Trial for Anti-TROP-2 Antibody Drug Conjugate (TROP-2 ADC) for multiple solid tumors
Published: 2021-10-13 (Crawled : 14:15) - globenewswire.com
SRNE | $0.028 1.82% -8.85% 42K
|
Health Technology
|
| O: 2.45%
H: 0.52%
C: -0.15%
fda clearance fda solid tumors antibody drug trial clearance
Cameco and Terrestrial Energy to Examine Partnerships for Deploying IMSR Generation IV Nuclear Power Plants
Published: 2021-10-13 (Crawled : 14:15) - globenewswire.com
CCJ | $48.41 0.46% -0.43% 2.3M
|
Non-Energy Minerals
|
| O: -0.78%
H: 6.5%
C: 5.51%
partnership energy trial
Industrial Robots Market in Automotive Industry to grow by USD 3.97 Bn | APAC to Occupy 67% Market Share | Technavio
Published: 2021-10-12 (Crawled : 14:15) - prnewswire.com
ABLZF | News | $45.744 1.54% -32.74% 1.5K
|
Producer Manufacturing
|
| O: -1.97%
H: 0.78%
C: -1.62%
SEKEY | $8.49 -1.44% -1.89% 22K
|
Manufacturing
|
| O: 0.05%
H: 0.0%
C: -0.51%
DNZOY | News | $18.56 -0.8% 0.08% 24K
|
Manufacturing
|
| O: -0.24%
H: 0.6%
C: 0.15%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 1.87%
H: 0.03%
C: -0.54%
automotive trial
Axalta expands Imron® Industrial portfolio with a new high-performance urethane DTM primer
Published: 2021-10-07 (Crawled : 14:15) - prnewswire.com
AXTA | $31.78 0.76% 2.39% 1.6M
|
Process Industries
|
| O: 0.99%
H: 2.95%
C: 2.21%
trial primec
Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities
Published: 2021-10-05 (Crawled : 14:15) - biospace.com/
NKTR | News | $1.35 -9.4% -10.78% 3.1M
|
Health Technology
|
| O: 0.06%
H: 1.55%
C: -5.41%
vaccine trial
Oncorus to Present Initial Data from its Ongoing Phase 1 Clinical Trial of ONCR-177 at the Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: -0.11%
H: 1.61%
C: 0.21%
immunotherapy ongoing phase 1 therapy cancer trial
Care Access and Eli Lilly and Company Partner to Increase Diversity Within Oncology Clinical Trials
Published: 2021-09-28 (Crawled : 14:15) - biospace.com/
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: -0.0%
H: 0.0%
C: -2.12%
clinical trials trials trial
Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Solid Tumors at ESMO Congress 2021
Published: 2021-09-14 (Crawled : 14:15) - biospace.com/
APRE | $5.73 -2.05% -1.29% 2.3K
|
Health Technology
|
| O: 1.82%
H: 6.7%
C: 0.89%
solid tumors phase 1 trial phase 2 phase 3
Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in The Lancet
Published: 2021-09-09 (Crawled : 14:15) - biospace.com/
ABBV | $164.25 1.05% 0.26% 3M
|
Health Technology
|
| O: -0.83%
H: 0.27%
C: -1.98%
GMAB | $28.53 -3.06% -3.23% 310K
|
Health Technology
|
| O: -1.2%
H: 0.95%
C: -0.77%
trial t-cell lancet
A functional magnetic resonance imaging investigation of prefrontal cortex deep transcranial magnetic stimulation efficacy in adults with attention deficit/hyperactive disorder: A double blind, randomized clinical trial
Published: 2021-09-08 (Crawled : 14:15) - brainsway.com
BWAY | News | $5.05 -1.17% -0.99% 17K
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: -1.6%
magnetic resonance trial imaging
Fall Protection Equipment Market to Record $ 715.23 Mn Incremental Growth| Top Vendors Include 3M Co., Bergman and Beving AB, Carl Stahl GmbH, Among Others| Analyzing Growth in Industrial Machinery Sector | Technavio
Published: 2021-08-27 (Crawled : 14:15) - prnewswire.com
HON | News M | $190.36 -0.19% -0.21% 2.4M
|
Producer Manufacturing
|
| O: 0.3%
H: 0.85%
C: -0.19%
growth trial
Rafael Pharmaceuticals Announces the Successful Completion of Phase 1b Clinical Trial and Initiates Phase 2 for CPI-613® (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer
Published: 2021-08-25 (Crawled : 14:15) - globenewswire.com
RFL 4 | $1.78 -1.11% -5.06% 8.2K
|
Finance
|
| O: 1.15%
H: 17.78%
C: 17.14%
phase 2 phase 1 cancer trial phase 1b cpi-613 gemcitabine phase 2b
Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
Published: 2021-08-23 (Crawled : 14:15) - diffusionpharma.com
FUSN | $21.24 -0.09% -0.09% 350K
|
Health Technology
|
| O: -2.52%
H: 1.48%
C: 0.31%
DFFN 4 | $6.6 11.68% -34.32% 350K
|
Health Technology
|
| O: -2.95%
H: 11.51%
C: 9.94%
positive oxygen trial
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.